| Domino's Pizza [DPZ] - Last Close: $349.79 An early-morning announcement is lifting shares of Domino's Pizza. This morning, the pizza delivery pioneer announced it has partnered with Uber [UBER] to facilitate delivery orders. The two companies have entered into a new global agreement that will allow customers to order Domino's products through Uber's food delivery apps. Domino's and its franchisees will continue to handle delivery for orders through Uber's app system. DPZ is leading the S&P 500 with a 9.8% gain on the news. My Take: This looks like a winner for DPZ, but the company has other issues to contend with. In April, it warned that the cost of living crisis could prompt a slowdown in its delivery business. This deal should help ease the pain, but I don't think it's an end-all solution to the company's troubles. Ault Alliance [AULT] - Last Close: $3.30 Ault Alliance just released a new letter to shareholders. This morning, the military-focused energy firm issued a letter to shareholders that contained several promising updates. In the letter, Ault Alliance projected strong financial growth and estimated it will notch $200 million in annual revenues this year. The company also said, "these positive projections are a testament to the strength of our business model and our commitment to create value for our stockholders." AULT is up 91.5% on active premarket trading volume. My Take: AULT has been heating up lately, and, with so much geopolitical uncertainty around the globe, I am bullish on tiny military suppliers like this. However, this is a very small float stock, so volatility could be an issue. Liminal BioSciences [LMNL] - Last Close: $5.92 Liminal Bio is rallying after announcing a buy out deal. This morning, the tiny biotech said it has agreed to a "go private" transaction with Structured Alpha LP that will pay shareholders $8.50 per share. The purchase price represents a 43.5% premium from LMNL's Tuesday closing price. Liminal CEO Bruce Pritchard said, "the transaction will deliver immediate value and liquidity to our minority shareholders at a substantial premium." The transaction is expected to close no later than Sept. 30th, 2023, according to the company's press release. News of the deal rallied LMNL to a 42.5% gain on elevated trading volume in today's premarket. My Take: There's not much upside left on the table for LMNL at this point. There's no point of trying to chase this one down if you already missed it. AVROBIO [AVRO] - Last Close: $0.9797 AVROBIO's early morning announcement is sending share prices higher. Moments ago, the tiny gene therapy firm announced plans to begin exploring strategic alternatives following the completion of a review of its businesses. AVROBIO said it has decided to halt further development of its programs, and it will conduct a comprehensive review to maximize shareholder value. Potential actions could include acquisition, merger, business combination, or other transaction, but here's no guarantee AVROBIO's efforts will result in a deal. AVRO is up 22.4% on the news. My Take: AVRO is dead in the water as far as the company is concerned, but the market is buying in hopes that the strategic review will result in a deal that will deliver a pay day. It's a speculative gamble, but it could work out if AVRO can make a deal. GainersHealthcare Triangle Place [TPHS] >> +126.6%Cadrenal Therapeutics [CVKD] >> +76.4%BitNile Metaverse [BNMV] >> +37.7%FLJ Group [FLJ] >> +25.5%DeclinersShiftPixy [PIXY] >> (30.9%) Silk Road Medical [SILK] >> (26.3%)Pain Reform [PRFX] >> (26.1%)Katapult [KPLT] >> (18.3%) Angiodynamics, Inc. [ANGO] ... AM
Millerknoll, Inc. [MLKN] ... PM
Ocean Power Technologies, Inc. [OPTT] ... PM Consumer price index [Jun] ... 8:30a | 